HHV-6 in AIDS.

PubWeight™: 1.76‹?› | Rank: Top 3%

🔗 View Article (PMID 7909128)

Published in Lancet on April 30, 1994

Authors

P D Griffiths, V C Emery, C Lee, M A Johnson, J McLaughlin

Articles citing this

Human herpesvirus 6. Clin Microbiol Rev (1997) 1.91

HHV-6 and CMV pneumonitis in immunocompromised patients. Lancet (1994) 0.84

HHV-6 and CMV pneumonitis in immunocompromised patients. Lancet (1994) 0.75

Articles by these authors

TOTAL ACID-BASE EQUILIBRIUM OF PLASMA IN HEALTH AND DISEASE: VII. Factors Causing Acidosis in Chronic Nephritis. A Preliminary Report. J Clin Invest (1926) 14.83

Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05

TOTAL ACID-BASE EQUILIBRIUM OF PLASMA IN HEALTH AND DISEASE: X. The Acidosis of Nephritis. J Clin Invest (1929) 10.24

TOTAL ACID-BASE EQUILIBRIUM OF PLASMA IN HEALTH AND DISEASE: VI. Studies of Diabetes. J Clin Invest (1925) 9.92

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell (1999) 9.84

Boron nitride substrates for high-quality graphene electronics. Nat Nanotechnol (2010) 9.72

Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet (1990) 8.56

Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res (2001) 7.27

Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci (1973) 6.62

TOTAL ACID-BASE EQUILIBRIUM OF PLASMA IN HEALTH AND DISEASE: XII. A Study of Renal Edema. J Clin Invest (1929) 6.48

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet (2004) 6.27

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene (2007) 5.79

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34

Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev (1996) 5.13

The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem (2005) 4.94

Cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst (2001) 4.80

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet (2000) 4.67

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology (1998) 4.01

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84

Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax (2004) 3.77

CDKN2A mutations in multiple primary melanomas. N Engl J Med (1998) 3.52

The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43

Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron (1999) 3.37

Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36

S-nitrosothiols signal the ventilatory response to hypoxia. Nature (2001) 3.26

Driving, glaucoma, and the law. BMJ (1994) 3.24

Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol (1993) 3.18

Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A (1987) 3.03

Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol (1998) 3.01

Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Lancet (1995) 2.90

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology (2005) 2.79

Criteria for diagnosing Parkinson's disease. Ann Neurol (1992) 2.78

Targeted disruption of the mPer3 gene: subtle effects on circadian clock function. Mol Cell Biol (2000) 2.69

The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun (1993) 2.67

Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet (1984) 2.65

TOTAL ACID-BASE EQUILIBRIUM OF PLASMA IN HEALTH AND DISEASE: XI. Hypochloremia and Total Salt Deficiency in Nephritis. J Clin Invest (1929) 2.64

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology (1992) 2.58

Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry (1996) 2.53

Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. Oncogene (2010) 2.53

Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene (1995) 2.50

Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48

Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron (1998) 2.46

A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol (1993) 2.46

A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet (1998) 2.44

Developing and deploying a patient safety program in a large health care delivery system: you can't fix what you don't know about. Jt Comm J Qual Improv (2001) 2.42

Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain (2000) 2.41

Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40

Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity. Nature (1984) 2.39

Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature (1983) 2.36

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci U S A (1990) 2.36

The effect of pupil dilation with tropicamide on vision and driving simulator performance. Eye (Lond) (2000) 2.35

Unilateral leptomeningeal enhancement after carotid stent insertion detected by magnetic resonance imaging. Stroke (2000) 2.33

The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int (2003) 2.32

Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res (2000) 2.28

Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27

Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol (2001) 2.26

Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23

The impact of childhood abuse and neglect on adult mental health: a prospective study. J Health Soc Behav (2001) 2.23

Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS (1996) 2.22

Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22

The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20

The dynamics of human cytomegalovirus replication in vivo. J Exp Med (1999) 2.19

Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A (1992) 2.18

Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18

Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol (1993) 2.17

Women's Health Australia: recruitment for a national longitudinal cohort study. Women Health (1998) 2.16

Neuroimaging for non-accidental head injury in childhood: a proposed protocol. Clin Radiol (2003) 2.15

Comparison of Doppler ultrasound, magnetic resonance angiographic techniques and catheter angiography in evaluation of carotid stenosis. Clin Radiol (2000) 2.11

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. J Infect Dis (2006) 2.09

Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet (2004) 2.09

Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08

Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury (2011) 2.07

Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07

Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet (1994) 2.05

Analgesia nociception index: evaluation as a new parameter for acute postoperative pain. Br J Anaesth (2013) 2.04

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol (2001) 2.01

A genetic epidemiological study of carcinoma of the fallopian tube. Gynecol Oncol (2001) 2.01

Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed (1998) 2.01

Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci U S A (1986) 1.97

On-line acquisition of the output of AutoAnalyzers. J Clin Pathol (1969) 1.96

Sulfhydryl group catalysis of charge transfer. Proc Natl Acad Sci U S A (1972) 1.96

Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2010) 1.96

Circadian regulation of a Drosophila homolog of the mammalian Clock gene: PER and TIM function as positive regulators. Mol Cell Biol (1998) 1.96

Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res (1997) 1.95

The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science (1987) 1.94

Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93

Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol (1996) 1.93

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet (1987) 1.89

Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J (1990) 1.89

The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med (2001) 1.88

Difficult extubation due to transfixation of a nasotracheal tube by a Kirschner wire. Anesthesiology (1977) 1.88

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS (2001) 1.86

The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol (1989) 1.84